Prudential Financial’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-36,400
Closed -$93.2K 2493
2025
Q1
$93.2K Hold
36,400
﹤0.01% 2136
2024
Q4
$68.4K Buy
+36,400
New +$68.4K ﹤0.01% 2181